Pediatr. praxi. 2026;27(2):78-80 | DOI: 10.36290/ped.2026.013

Atypical forms of invasive meningococcal disease

Mgr. Zuzana Okonji1, 4, MUDr. Pavla Křížová, CSc.1, MUDr. Vyacheslav Grebenyuk2, MUDr. Milan Trojánek, Ph.D.2, doc. MUDr. Jan David, Ph.D.3, 4
1 Národní referenční laboratoř pro meningokokové nákazy, Státní zdravotní ústav, Praha
2 Klinika infekčních nemocí a cestovní medicíny 2. lékařské fakulty a Fakultní nemocnice Motol a Homolka, Praha
3 Klinika dětí a dorostu Fakultní nemocnice Královské Vinohrady, Praha
4 3. lékařská fakulta Univerzity Karlovy, Praha

The diagnosis of invasive meningococcal disease is often challenging, particularly due to the rapid progression of this life-threatening disease. Cases with predominantly atypical symptoms are even more complicated. These may include pneumonia or pleuritis, perimyocarditis, conjunctivitis, urethritis, arthritis or abdominal symptoms. These less common forms have come to the forefront of attention following the COVID-19 pandemic, as they are beginning to appear more frequently in some countries. The epidemiological situation in the Czech Republic currently appears favourable; however, careful monitoring and vaccination against this disease remain essential.

Keywords: Neisseria meningitidis, epidemiology, perimyocarditis, abdominal form, pneumonia, pleuritis, conjunctivitis, urethritis, arthritis.

Accepted: April 22, 2026; Published: April 28, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Okonji Z, Křížová P, Grebenyuk V, Trojánek M, David J. Atypical forms of invasive meningococcal disease. Pediatr. praxi. 2026;27(2):78-80. doi: 10.36290/ped.2026.013.
Download citation

References

  1. Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021; 3(6): e360-e370. Go to original source...
  2. Okonji Z, Křížová P, Musílek M, et al. Invazivní meningokokové onemocnění v České republice v roce 2024. Zprávy Centra epidemiologie a mikrobiologie. 2025;34(3-4):107-115.
  3. Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive menin­gococcal disease: a narrative review. Infect Dis (Lond). 2022;54(1):1-7. Go to original source... Go to PubMed...
  4. Apicella MA. Extrameningeal complications of Neisseria meningitidis serogroup W135 infection. Clin Infect Dis. 2004;3(11):1638-1639. Go to original source... Go to PubMed...
  5. Campbell H, Andrews N, Parikh S, et al. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. J Infect. 2020;80(2):182-189. Go to original source...
  6. Loenenbach AD, van der Ende A, de Melker HE, et al. The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015-2018. Clin Infect Dis. 2020;70(10):2036-2044. Go to original source... Go to PubMed...
  7. Steele L, Bechman K, De Barra E, et al. Meningococcal arthritis and myopericarditis: a case report. BMC Infect Dis. 2017;17(1):751. Go to original source... Go to PubMed...
  8. Säll O, Stenmark B, Jacobsson S, et al. Atypical presentation of Neisseria meningitidis serogroup W disease is associated with the introduction of the 2013 strain. Epidemiol Infect. 2021;149:e126. Go to original source...
  9. Stinson C, Burman C, Presa J, et al. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12. Go to original source... Go to PubMed...
  10. Taha S, Deghmane AE, Taha MK. Recent increase in atypical presentations of invasive meningococcal disease in France. BMC Infect Dis. 2024;24(1):640. Go to original source...
  11. Benes J, Dzupova O, Kabelkova M, et al. Infective endocarditis due to Neisseria meningitidis: two case reports. Clin Microbiol Infect. 2003;9:1062-1064. Go to original source... Go to PubMed...
  12. Krbková L, Fedora M, Pavelka J, et al. Fatální meningokoková sepse způsobená Neisseria meningitidis séroskupiny W. Ces-slov Pediat. 2017;72(5):322-324.
  13. Kulichová J, Křížová P, Okonji Z, et al. Meningokoková pyomyositida způsobená Neisseria meningitidis skupiny C u zdravého mladého muže jako neobvyklá forma invazivního meningokokového onemocnění. Medicina praxi. 2019; 16(4):270-274. Go to original source...
  14. Ricci S, Montemaggi A, Nieddu F, et al. Is primary meningococcal arthritis in children more frequent than we expect? Two pediatric case reports revealed by molecular test. BMC Infect Dis. 2018;18(1):703. Go to original source... Go to PubMed...
  15. Finkelstein Y, Adler Y, Nussinovitch M, et al. A new classification for pericarditis associated with meningococcal infection. Eur J Pediatr. 1997;156(8):585-588. Go to original source...
  16. Krejčová V, Špičáková K, David J, et al. Nezapomínejme na meningokoka. Ces-slov Pediat. 2021;76(7):374-378.
  17. Vossen M, Mitteregger D, Steininger C. Meningococcal pneumonia. Vaccine. 2016;34(37):4364-4370. Go to original source... Go to PubMed...
  18. Stinson C, Burman C, Presa J, et al. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.